cafepharma
ADC market will remain hot in oncology, reaching $30B by 2028—Bristol Myers Squibb reports data from Phase III multiple sclerosis trial—RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest--http://bit.ly/w28kSd #antibodydrugconjugates #oncology #clinicaltrials #mutliplesclerosis #rsv #vaccines #bristolmyerssquibb #guillainbarre #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
Mar 1, 2024 at 5:12pmWeb